Free Trial
NYSE:CVM

CEL-SCI (CVM) Stock Price, News & Analysis

CEL-SCI logo
$9.33 +0.02 (+0.20%)
As of 10:00 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About CEL-SCI Stock (NYSE:CVM)

Key Stats

Today's Range
$9.06
$9.51
50-Day Range
$2.29
$13.04
52-Week Range
$1.98
$39.30
Volume
75,793 shs
Average Volume
371,199 shs
Market Capitalization
$64.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CEL-SCI Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
11th Percentile Overall Score

CVM MarketRank™: 

CEL-SCI scored higher than 11% of companies evaluated by MarketBeat, and ranked 903rd out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for CEL-SCI.

  • Earnings Growth

    Earnings for CEL-SCI are expected to grow in the coming year, from ($0.29) to ($0.18) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of CEL-SCI is -19.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of CEL-SCI is -19.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    CEL-SCI has a P/B Ratio of 62.07. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    11.25% of the float of CEL-SCI has been sold short.
  • Short Interest Ratio / Days to Cover

    CEL-SCI has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in CEL-SCI has recently decreased by 50.60%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    CEL-SCI does not currently pay a dividend.

  • Dividend Growth

    CEL-SCI does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    11.25% of the float of CEL-SCI has been sold short.
  • Short Interest Ratio / Days to Cover

    CEL-SCI has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in CEL-SCI has recently decreased by 50.60%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for CEL-SCI this week, compared to 1 article on an average week.
  • Search Interest

    Only 5 people have searched for CVM on MarketBeat in the last 30 days. This is a decrease of -64% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added CEL-SCI to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, CEL-SCI insiders have bought more of their company's stock than they have sold. Specifically, they have bought $219,995.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 9.93% of the stock of CEL-SCI is held by insiders.

  • Percentage Held by Institutions

    Only 12.08% of the stock of CEL-SCI is held by institutions.

  • Read more about CEL-SCI's insider trading history.
Receive CVM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CEL-SCI and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CVM Stock News Headlines

$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.tc pixel
CEL-SCI Announces Pricing of $10 Million Public Offering
CEL-SCI Announces Proposed Public Offering
CEL-SCI (NYSE:CVM) Trading 10.9% Higher - Should You Buy?
See More Headlines

CVM Stock Analysis - Frequently Asked Questions

CEL-SCI's stock was trading at $11.9970 at the beginning of the year. Since then, CVM shares have decreased by 22.4% and is now trading at $9.31.

CEL-SCI Co. (NYSE:CVM) issued its quarterly earnings data on Thursday, August, 15th. The company reported ($4.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($3.90) by $0.30.

CEL-SCI's stock reverse split on the morning of Thursday, June 15th 2017.The 1-25 reverse split was announced on Monday, June 12th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, June 14th 2017. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Top institutional investors of CEL-SCI include MAI Capital Management (0.94%), Bank of America Corp DE (0.60%), Geode Capital Management LLC (0.49%) and Group One Trading LLC. Insiders that own company stock include Geert R Kersten, Patricia B Prichep and Robert Eugene Watson.
View institutional ownership trends
.

Shares of CVM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CEL-SCI investors own include Dynavax Technologies (DVAX), Sorrento Therapeutics (SRNE), TG Therapeutics (TGTX), Advanced Micro Devices (AMD), Pfizer (PFE), Canopy Growth (CGC) and Inovio Pharmaceuticals (INO).

Company Calendar

Last Earnings
8/15/2024
Today
8/29/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:CVM
CIK
725363
Employees
43
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($9.77)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$26.92 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-238.05%
Return on Assets
-104.65%

Debt

Debt-to-Equity Ratio
0.66
Current Ratio
1.07
Quick Ratio
1.09

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.15 per share
Price / Book
62.07

Miscellaneous

Outstanding Shares
6,882,000
Free Float
64,673,000
Market Cap
$64.07 million
Optionable
Optionable
Beta
0.52

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NYSE:CVM) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners